tirzepatide vs semaglutide weight loss side effects comparison caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide tirzepatide and semaglutide therapeutic modality

FDA approval of Foundayo, the only approved GLP-1 pill that can be taken any time of day, without food and water restrictions

Not in the beginning, because the FDA really doesn't want you to promote weight loss

its sister brand Mounjaro (same active ingredient tirzepatide) is the version specifically labeled for diabetes management

For cervical cancer specifically, clinical and population-level analyses show that AC and adenosquamous carcinomas (ASC) have poorer local control and survival after definitive radiotherapy or chemoradiotherapy compared with SCCs, consistent with increased intrinsic radioresistance in many AC cohorts [184]